Summit expands its offering with soft chew formulations
)
“Joining the Swedencare family has given us access to its
globally patented soft chew technology, as well as valuable insights from
colleagues with extensive experience in these formulations. Their knowledge has
complemented the expertise within our own team as we worked to expand our
manufacturing capabilities and bring this exciting dosage form to market”, says
Owain Hughes, Operations Director at Summit.
This has been a collaborative journey with the goal of
creating a great tasting product, without compromising the active ingredient.
Developing a pharmaceutical product in a soft chew format presents unique
challenges, requiring careful balancing of acceptance factors (aroma, flavour,
texture) with the formulation of a stable, consistent product. Throughout the
process, our focus has remained firmly on maintaining the quality that
clinicians expect.
The introduction of this dosage form opens new
possibilities for veterinary pharmaceutical delivery. Soft chews offer a
practical alternative where traditional administration methods may present
challenges, helping to reduce barriers to treatment and support better
compliance.
This expansion reflects Summit’s continued focus on
identifying and addressing unmet treatment needs among veterinary patients.
Every patient is different, and expanding the range of formulations available
gives clinicians greater flexibility to tailor treatment decisions to the
individual patient and the practical realities faced by owners. The
introduction of soft chew formulations represents another step in Summit’s
commitment to supporting veterinary surgeons in delivering the best possible
care, creating better treatment experiences and improving outcomes for
patients.
For more information, please contact:
Rachel Bell, Head of Commercial
Rachel.Bell@svprx.co.uk
){kind=logo}
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)
){kind=logo}
){kind=logo}
){kind=logo}